Search Results for "Plasma Binding In Beta Blockers Wikipedia"

06:57 EDT 25th April 2015 | BioPortfolio

Matching Channels

Matching News

Beta-blockers have no mortality benefit in post-heart attack patients, say researchers

(Elsevier Health Sciences) Beta-blockers have been a cornerstone in the treatment of heart attack survivors for more than a quarter of a century. However, many of the data predate contemporary medical...

Dialysis and Beta Blockers Are Not Always a Good Match

For patients undergoing chronic hemodialysis, not all beta blockers are created equal, according to a new study. Medscape Medical News

Beta-Blockers Show No Benefits After Heart Attack

Beta-blockers offer no survival advantages to patients, post-heart attack, but they do improve survival among some heart failure patients.Read more about Beta-Blockers Show No Benefits After Heart Att...

Beta-Blockers Reduce Mortality in Diastolic Heart Failure

Swedish registry data show beta-blockers reduce all-cause mortality in HF patients with preserved EF but not the combined end point of all-cause mortality or first hospitalization for HF. He...

Evidence lacking for widespread use of beta-blockers in CHD

(HealthDay)—There is currently insufficient data to support the use of β-blockers for all patients with clinically stable coronary heart disease (SCHD), according to a paper published in the Nov. 1...

Beta blockers could benefit patients with HFPEF

A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today la...

Use of beta-blockers for certain type of heart failure linked with improved survival

(The JAMA Network Journals) Lars H. Lund, M.D., Ph.D., of the Karolinska Institutet, Stockholm, Sweden, and colleagues conducted a study to examine whether beta-blockers are associated with reduced mo...

Removal of heart medications by dialysis may increase kidney failure patients' risk of dying prematurely

Among kidney failure patients on dialysis, beta blockers that are easily removed from the circulation through dialysis were linked with a higher risk of premature death than beta blockers that are not...

Matching PubMed Articles

Appropriate Usage of Beta-Blockers Improves Outcome in Trauma Patients Admitted to the Intensive Care Unit.

Outcomes/Quality Control Posters IISESSION TYPE: Original Investigation PosterPRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PMPURPOSE: Beta-blockers are used to reduce heart rate (HR) ...

Atenolol versus Losartan in Marfan's Syndrome.

To the Editor: Lacro et al. (Nov. 27 issue)(1) report no benefit of losartan, an angiotensin-receptor blocker (ARB), over the beta-blocker atenolol in respect to the rate of aortic-root dilatation in ...

Atenolol versus Losartan in Marfan's Syndrome.

To the Editor: Lacro et al. (Nov. 27 issue)(1) report no benefit of losartan, an angiotensin-receptor blocker (ARB), over the beta-blocker atenolol in respect to the rate of aortic-root dilatation in ...

Atenolol versus Losartan in Marfan's Syndrome.

To the Editor: Lacro et al. (Nov. 27 issue)(1) report no benefit of losartan, an angiotensin-receptor blocker (ARB), over the beta-blocker atenolol in respect to the rate of aortic-root dilatation in ...

Atenolol versus Losartan in Marfan's Syndrome.

To the Editor: Lacro et al. (Nov. 27 issue)(1) report no benefit of losartan, an angiotensin-receptor blocker (ARB), over the beta-blocker atenolol in respect to the rate of aortic-root dilatation in ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement